New Approaches to Develop Drug Treatment for Alzheimer’s Disease: Targeting Calcium Dysregulation-Reference-Cited by-同舟云学术

New Approaches to Develop Drug Treatment for Alzheimer’s Disease: Targeting Calcium Dysregulation

Published:2020-06-29 Issue:4 Volume:17 Page:311-312
ISSN:1567-2050
Container-title:Current Alzheimer Research
language:en
Short-container-title:CAR

Author:

Wei Huafeng¹

Affiliation:

1. Department of Anesthesiology and Critical Care University of Pennsylvania Perelman School of Medicine 305 John Morgan Building 3620 Hamilton Walk Philadelphia, PA 19104, United States

Publisher

Bentham Science Publishers Ltd.

Subject

Neurology (clinical),Neurology

Reference10 articles.

1. Peng J.; Liang G.; Inan S.; Wu Z.; Joseph D.J.; Meng Q.; Peng Y.; Eckenhoff M.F.; Wei H.; Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice. Neurosci Lett 2012,516(2),274-279

2. Chakroborty S.; Briggs C.; Miller M.B.; Goussakov I.; Schneider C.; Kim J.; Wicks J.; Richardson J.C.; Conklin V.; Cameransi B.G.; Stutzmann G.E.; Stabilizing ER Ca(2+) Channel function as an early preventative strategy for Alzheimer's disease. PLoS One 2012,7(12)

3. Oules B.; Del Prete D.; Greco B.; Zhang X.; Lauritzen I.; Sevalle J.; Moreno S.; Paterlini-Bréchot P.; Trebak M.; Checler F.; Benfenati F.; Chami M.; Ryanodine receptor blockade reduces amyloid-beta load and memory impairments in Tg2576 mouse model of Alzheimer disease. J Neurosci 2012,32(34),11820-11834

4. Chami M.; Checler F.; Targeting Post-translational remodeling of ryanodine receptor: A new track for Alzheimer’s disease therapy? Curr Alzheimer Res 2020,17(4),313-323

5. Abou M.B.; Sun L.; Wei H.; Approaches to optimizing dantrolene neuroprotection for treatment of Alzheimer’s disease. Curr Alzheimer Res 2020,17(4),324-328

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ketamine Induces Delirium-Like Behavior and Interferes With Endosomal Tau Trafficking;Anesthesia & Analgesia;2022-07-25